Sensus Healthcare
SRTS
49 hedge funds and large institutions have $10.8M invested in Sensus Healthcare in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 21 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 18
9.06% less ownership
Funds ownership: 29.88% → 20.82% (-9.1%)
27% less funds holding
Funds holding: 67 → 49 (-18)
58% less capital invested
Capital invested by funds: $25.5M → $10.8M (-$14.8M)
86% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$566K |
| 2 |
Renaissance Technologies
New York
|
+$332K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$291K |
| 4 |
Two Sigma Investments
New York
|
+$144K |
| 5 |
Two Sigma Advisers
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
-$2.29M |
| 2 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$2.27M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.12M |
| 4 |
EWM
Empirical Wealth Management
Seattle,
Washington
|
-$1M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$632K |
SRTS Hedge Fund Activity: Q2 2023 in Review
49 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Sensus Healthcare (SRTS) for Q2 2023, worth a combined $10.8M — down 58% from $25.5M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of SRTS and 3 opened new positions — a net loss of 18 holders — while 18 trimmed existing stakes and 19 added.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $566K. The largest seller was Hillsdale Investment Management, exiting entirely with an estimated $2.29M sold.
- 49 institutional investors held Sensus Healthcare (SRTS) as of Q2 2023, down from 67 in Q1 2023.
- Funds reported $10.8M of Sensus Healthcare stock for Q2 2023, down 58% quarter-over-quarter.
- 3 funds opened new Sensus Healthcare positions in Q2 2023 and 21 closed out, a net change of -18 holders.
- The largest Sensus Healthcare buyer in Q2 2023 was GSA Capital Partners, an estimated $566K added.
- The largest Sensus Healthcare seller in Q2 2023 was Hillsdale Investment Management, an estimated $2.29M sold.
Based on aggregated 13F filings for Q2 2023.